Fight Cancer Like a Man: A Breakthrough Treatment for Prostate Cancer Without Surgery, Radiation, or Sacrificing Your Manhood

You have been told your PSA is elevated. Or your MRI found something suspicious. Or the word cancer has already been said out loud in a doctor's office.

Before you agree to anything — read this book.

For over a century men have been funneled into biopsies, prostatectomies, radiation, and chemical castration based on a playbook that has never been proven to save lives. The ProtecT trial, the PIVOT trial, and the 2023 New England Journal of Medicine study followed over 1,500 men and reached the same conclusion — aggressive intervention offers no survival advantage over careful monitoring. What it does offer is guaranteed harm. Incontinence. Erectile dysfunction. Testosterone annihilation.

In Fight Cancer Like a Man, Dr. Stephen Petteruti, a board certified family physician, fellowship trained in Anti-Aging and Regenerative Medicine, 30 years of clinical experience — dismantles the fear-based system driving prostate cancer care and replaces it with a protocol built on evidence, precision, and the preservation of everything that makes a man vital.

What you will learn:

PSA is a signal, not a verdict. Trends over time matter. A single number is not a reason to agree to your next procedure.

Biopsies breach the only barrier protecting you. An 18-gauge needle inserted 10 to 18 times through the rectal wall creates escape routes for cancer cells. No surgery or radiation planned? No biopsy needed.

Focal therapies don't solve the problem. HIFU, TULSA, and cryotherapy target what the scan shows. Cancer exists throughout the gland at a microscopic level long before imaging detects it. Destroying one spot does not address the rest and long-term survival data does not support the trade-off.

MRI done right. Non-contrast prostate MRI provides a complete picture without needles, without gadolinium, and without capsule disruption. This is the tool that should drive every decision.

The full diagnostic toolkit. PSA trend. PHI scoring. EpiSwitch PSC. ExoDx. PSMA PET scan. What each measures, what each cannot tell you, and how to use them together without invasive procedures.

The testosterone truth. Low testosterone raises cancer risk — not the reverse. The prostate saturation theory, the Morgentaler research, and why optimizing testosterone may be one of the most important decisions a man with prostate cancer can make.

ADT is a last resort. Chemical castration causes heart disease, osteoporosis, depression, muscle loss, and erectile dysfunction. The TOAD trial and CaPSURE registry showed no survival advantage for early ADT. Persistently low testosterone can trigger conversion to an incurable cancer form. Testosterone Mitigation Therapy changes the equation.

The repurposed drug protocol. Low dose naltrexone. Doxycycline. Atorvastatin. Metformin. Ivermectin. Sirolimus. Mebendazole. Each backed by peer reviewed research with dosing rationale and mechanism of action explained.

Heavy metal detoxification. Every patient tested over 20 years showed elevated cadmium and lead. Both drive cancer. Both are addressable. The DMSA protocol is explained in full.

The principle that changes everything. You cannot die from prostate cancer unless it leaves the gland. The entire protocol exists to keep it there.

Order Fight Cancer Like a Man today. Read it before you sign anything.

Legal Disclaimer: For informational purposes only. Not a substitute for advice from a qualified physician.